MXCT PEER ANALYSIS

MaxCyte Inc — metric-by-metric comparison with peers and the industry median

MXCTMaxCyte Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value it Duel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile

MXCTIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	MXCT	ONCSM	SN	MEDTR	ANGEN	4DX	Ind. Median
P/E	—	122.41	20.73●	596.83	—	—	26.82
P/B	0.81	13.36	2.50	1.08	1.32	-76.08●	2.50
EV/EBITDA	—	25.46	9.94●	10.93	34.77	—	15.54
P/S	4.20	7.66	2.10	1.18●	2.95	249.46	2.69

Financial Health
Metric	MXCT	ONCSM	SN	MEDTR	ANGEN	4DX	Ind. Median
Current Ratio	12.04●	2.25	2.57	3.58	2.31	6.57	3.28
Debt/Equity	10.4%	35.0%	62.9%	1.0%	28.1%	-22.6%●	44.7%
NetDebt/EBITDA	-0.08	0.42	1.72	-1.64●	4.71	0.71	0.82

Profitability
Metric	MXCT	ONCSM	SN	MEDTR	ANGEN	4DX	Ind. Median
Net Margin	-121.2%	6.3%	10.1%●	0.2%	-45.0%	-3,684.6%	-5.7%
ROE	-21.3%	12.9%●	12.1%	0.2%	-21.0%	—	-8.6%
ROA	-18.4%	8.0%●	6.1%	0.2%	-15.7%	-264.3%	-6.4%
EBITDA Margin	-107.3%	30.6%●	25.6%	9.4%	9.8%	-818.8%	5.2%

Growth + Dividend
Metric	MXCT	ONCSM	SN	MEDTR	ANGEN	4DX	Ind. Median
Rev. Growth	-14.3%	39.1%●	—	6.5%	11.7%	-26.0%	7.4%
NI Growth	—	—	—	-62.9%	—	—	16.7%
Div. Yield	—	0.0%	3.5%●	1.1%	0.0%	—	1.1%
Payout	—	0.0%	52.8%	656.3%	0.0%	—	39.0%

Valuation
Metric	MXCT	CVRX	INGN	NNOX	OM	QSI	Ind. Median
P/E	—	—	—	—	—	—	26.82
P/B	0.81	5.10	1.00	0.70●	0.84	1.03	2.50
EV/EBITDA	—	—	—	—	—	—	15.54
P/S	4.20	2.51	0.52●	6.10	0.79	111.24	2.69

Financial Health
Metric	MXCT	CVRX	INGN	NNOX	OM	QSI	Ind. Median
Current Ratio	12.04	10.20	3.10	3.64	6.29	12.60●	3.28
Debt/Equity	10.4%	204.0%	9.3%	6.0%	91.0%	1.8%●	44.7%
NetDebt/EBITDA	-0.08●	0.28	18.07	0.74	0.96	1.35	0.82

Profitability
Metric	MXCT	CVRX	INGN	NNOX	OM	QSI	Ind. Median
Net Margin	-121.2%	-89.1%	-7.1%●	-523.8%	-63.7%	-5,605.9%	-5.7%
ROE	-21.3%	-107.0%	-13.1%●	-50.1%	-53.2%	-46.4%	-8.6%
ROA	-18.4%	-45.9%	-8.4%●	-44.4%	-27.2%	-42.9%	-6.4%
EBITDA Margin	-107.3%	-77.8%	-1.5%●	-336.6%	-48.6%	-4,942.7%	5.2%

Growth + Dividend
Metric	MXCT	CVRX	INGN	NNOX	OM	QSI	Ind. Median
Rev. Growth	-14.3%	11.7%	3.4%	25.7%●	2.0%	-46.2%	7.4%
NI Growth	—	—	—	—	—	—	16.7%
Div. Yield	—	—	—	—	—	—	1.1%
Payout	—	—	—	—	—	—	39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on MXCT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.